A new study published in the journal Mindfulness has found that high-precision brain training can help novice meditators ...
Mumbai doctors have successfully resolved a complex neurological case involving a 35-year-old nurse diagnosed with myasthenia gravis based on a positive antibody test and started on long-term ...
While the latest UK Government report into animal testing was keen to highlight a (very slight) decrease from 2.67 million ...
Michigan Medicine opened the Brain-Computer Interface Clinic to provide assessments for patients with speech and motor ...
Findings from the LEAP2MONO study support the regulatory submission of venglustat for treatment of type 3 Gaucher disease.
18h
A 'window to the brain': Chip tracks glioblastoma treatment response using tumor vesicles in blood
Technology created at the University of Queensland could improve the odds of surviving brain cancer and change how we treat a range of neurological conditions. Dr. Richard Lobb and Dr. Zhen Zhang from ...
Sanofi will take venglustat to regulators for Gaucher disease but an application for Fabry disease is less clear after the failure of a Phase III trial.
Dr. Srividya Shivakumar, Director, School of Allied Healthcare & Sciences, JAIN (Deemed-to-be University), says: "Neuropsychology is where science meets sensitivity. This Program is built to develop ...
BBC Sport's Ask Me Anything team explain what is involved in a medical exam when a football player joins a new club.
Sanofi’s venglustat met all primary endpoints in a phase 3 study of type 3 Gaucher diseaseIn the LEAP2MONO phase 3 study, venglustat, dosed ...
Schizophrenia is a severe and often highly debilitating psychiatric disorder characterized by distorted emotions, thinking patterns and altered perceptions of reality, as well as mental impairments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results